For example, a panel of markers, such as TYMP, LAP3, ANXA, and SULF1, along with traditional tuberculosis‐related symptoms such as persistent cough, weight loss, and fever, can be used to differentiate between patients with cancer, post‐SARS‐CoV‐2 infection, and those at risk for tuberculosis. This evidence concerns the gene SULF1 and cancer.